Kancera AB (OSTO:KAN) Tax Rate % : 0.00% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Kancera AB Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Kancera AB's Tax Expense for the three months ended in Mar. 2024 was kr0.00 Mil. Kancera AB's Pre-Tax Income for the three months ended in Mar. 2024 was kr-12.96 Mil. Therefore, Kancera AB's Tax Rate % for the quarter that ended in Mar. 2024 was 0.00%.

Kancera AB Tax Rate % Historical Data

The historical data trend for Kancera AB's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kancera AB Tax Rate % Chart

Kancera AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Tax Rate %

Get a 7-Day Free Trial

Kancera AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

Kancera AB Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Kancera AB's Tax Rate % for the fiscal year that ended in Dec. 2022 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2022 )	/	Pre-Tax Income (A: Dec. 2022 )
	=	0	/	-52.484
	=	0.00 %

Kancera AB's Tax Rate % for the quarter that ended in Mar. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2024 )	/	Pre-Tax Income (Q: Mar. 2024 )
	=	0	/	-12.961
	=	0.00 %

Kancera AB Tax Rate % Related Terms

Thank you for viewing the detailed overview of Kancera AB's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kancera AB (OSTO:KAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kancera AB (OSTO:KAN) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

3EE0:Germany

Address

Karolinska Institutet Science Park, Banvaktsvagen 22, Solna, SWE, 171 48

Website

http://www.kancera.com

Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.

Kancera AB (OSTO:KAN) Headlines

No Headlines